Supplementary Figure S1 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer | Synapse
September 3, 2024
Supplementary Figure S1 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S1. CEA kinetics in patients with stable disease at first response assessment.